About this course
Type 2 diabetes mellitus (T2DM) is one of the most common metabolic disorders worldwide. Initial treatment begins with oral medications; however, many patients will eventually require exogenous insulin. Around 50% of patients with diabetes complications had a delay in treatment with insulin. Therefore, it is imperative that healthcare practitioners know how to address the barriers in treatment delay in T2DM patients requiring insulin. This e-learning module identifies the barriers and causes of treatment delay in insulin treatment and summarizes the principles on how to start insulin in T2DM patients.
Upon completion of the educational activity, participants should be able to
- Identify delays and barriers in insulin treatment
- Determine when to start insulin therapy in T2DM
- Enumerate and differentiate available insulin types and delivery systems
- Understand how to start and titrate insulin
- Treatment delays and barriers in insulin treatment
- Insulin: Overview, types, delivery systems
- Principles of insulin treatment
1 CME Point Available
- This module is accredited for 1 CME Point for medical practitioners enrolled in The Medical Council of Hong Kong’s Continuing Medical Education Programme for Practising Doctors who are not taking CME for Specialists.
- This module is accredited for both Hong Kong Doctors Union (HKDU) members and non-members
- This module is accredited for 1 CME Point for fellows of the Hong Kong College of Physicians.
- Please note that this module will not earn CME credit for fellows of colleges not listed here.
- A certificate can be downloaded upon successful completion of the quiz. Please use the information on the certificate to claim your CME points.